Pembrolizumab Brings Heavy Toxicity Burden for Older Breast Cancer Patients in Real-World Care
A real-world cohort study of 136 patients aged 65 and older found high rates of hospitalization and immune-related toxicity with ...
A real-world cohort study of 136 patients aged 65 and older found high rates of hospitalization and immune-related toxicity with ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine